Stephen R. Petteway Jr.

All filings by Stephen R. Petteway Jr. on record concern Talecris Biotherapeutics Holdings Corp. We count 17 filings; the first trade dates from 30 September 2009 and the latest from 1 June 2011.

The open-market record consists of 6 sales worth €2.6M, with no purchase. The rest of the record consists of 4 share grants and 6 option exercises. In 2011 alone, the filings show no purchases and 2 sales.

The record was last updated on 3 June 2011 with a transaction in Talecris Biotherapeutics Holdings Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.